126 related articles for article (PubMed ID: 35737751)
1. Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell disease.
Sharma A; Leonard A; West K; Gossett JM; Uchida N; Panch S; Stroncek D; Poston L; Akel S; Hankins JS; Fitzhugh C; Hsieh MM; Kang G; Tisdale JF; Weiss MJ; Zheng Y
Br J Haematol; 2022 Aug; 198(4):740-744. PubMed ID: 35737751
[TBL] [Abstract][Full Text] [Related]
2. Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease.
Leonard A; Sharma A; Uchida N; Stroncek D; Panch SR; West K; Molloy E; Hughes TE; Hauffe S; Taylor T; Fitzhugh C; Hankins JS; Wilson M; Tsai SQ; Weiss MJ; Hsieh M; Tisdale JF
Blood Adv; 2021 May; 5(9):2403-2411. PubMed ID: 33956057
[TBL] [Abstract][Full Text] [Related]
3. Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients.
Esrick EB; Manis JP; Daley H; Baricordi C; Trébéden-Negre H; Pierciey FJ; Armant M; Nikiforow S; Heeney MM; London WB; Biasco L; Asmal M; Williams DA; Biffi A
Blood Adv; 2018 Oct; 2(19):2505-2512. PubMed ID: 30282642
[TBL] [Abstract][Full Text] [Related]
4. Evidence for continued dose escalation of plerixafor for hematopoietic progenitor cell collections in sickle cell disease.
Boulad F; Zhang J; Yazdanbakhsh K; Sadelain M; Shi PA
Blood Cells Mol Dis; 2021 Sep; 90():102588. PubMed ID: 34166998
[TBL] [Abstract][Full Text] [Related]
5. Mobilized and apheresis-collected endothelial progenitor cells with plerixafor.
Perdomo S; Brugnini A; Trias N; Menyou A; Silveira G; Ranero S; Lens D; Díaz L; Grille S
J Clin Apher; 2022 Jun; 37(3):245-252. PubMed ID: 35114004
[TBL] [Abstract][Full Text] [Related]
6. Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixafor.
Uchida N; Leonard A; Stroncek D; Panch SR; West K; Molloy E; Hughes TE; Hauffe S; Taylor T; Fitzhugh C; Hankins JS; Wilson M; Sharma A; Tsai SQ; Weiss MJ; Hsieh M; Tisdale JF
Haematologica; 2020 Oct; 105(10):e497. PubMed ID: 33054091
[No Abstract] [Full Text] [Related]
7. Poor stem cell harvest may not always be related to poor mobilization: lessons gained from a mobilization study in patients with β-thalassemia major.
Constantinou VC; Bouinta A; Karponi G; Zervou F; Papayanni PG; Stamatoyannopoulos G; Anagnostopoulos A; Yannaki E
Transfusion; 2017 Apr; 57(4):1031-1039. PubMed ID: 27987208
[TBL] [Abstract][Full Text] [Related]
8. Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease.
Avecilla ST; Boulad F; Yazdanbakhsh K; Sadelain M; Shi PA
Transfusion; 2021 Sep; 61(9):2775-2781. PubMed ID: 34160085
[TBL] [Abstract][Full Text] [Related]
9. Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi-center HGB-206 trial.
Tisdale JF; Pierciey FJ; Bonner M; Thompson AA; Krishnamurti L; Mapara MY; Kwiatkowski JL; Shestopalov I; Ribeil JA; Huang W; Asmal M; Kanter J; Walters MC
Am J Hematol; 2020 Sep; 95(9):E239-E242. PubMed ID: 32401372
[No Abstract] [Full Text] [Related]
10. Use of plerixafor to mobilize haematopoietic progenitor cells in healthy donors.
Romon I; Castillo C; Cid J; Lozano M
Vox Sang; 2022 Jan; 117(1):6-16. PubMed ID: 34159611
[TBL] [Abstract][Full Text] [Related]
11. Development of a quantitative prediction model for peripheral blood stem cell collection yield in the plerixafor era.
Ishii A; Jo T; Arai Y; Oshima S; Kanda J; Kitawaki T; Matsui K; Niwa N; Nakagawa Y; Takaori-Kondo A; Nagao M
Cytotherapy; 2022 Jan; 24(1):49-58. PubMed ID: 34654641
[TBL] [Abstract][Full Text] [Related]
12. EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid Tumors.
Karres D; Ali S; van Hennik PB; Straus S; Josephson F; Thole G; Glerum PJ; Herberts C; Babae N; Herold R; Papadouli I; Pignatti F
Oncologist; 2020 Jun; 25(6):e976-e981. PubMed ID: 32154610
[TBL] [Abstract][Full Text] [Related]
13. Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion.
Lagresle-Peyrou C; Lefrère F; Magrin E; Ribeil JA; Romano O; Weber L; Magnani A; Sadek H; Plantier C; Gabrion A; Ternaux B; Félix T; Couzin C; Stanislas A; Tréluyer JM; Lamhaut L; Joseph L; Delville M; Miccio A; André-Schmutz I; Cavazzana M
Haematologica; 2018 May; 103(5):778-786. PubMed ID: 29472357
[TBL] [Abstract][Full Text] [Related]
14. Impact of mobilization regimen on multiday collection of peripheral blood CD34+ cells by large volume leukapheresis.
Siddiqui I; Shmookler A; Biller E; Hardy T; Hartage R; Losos M; Chen J
Transfusion; 2022 Apr; 62(4):857-862. PubMed ID: 35211978
[TBL] [Abstract][Full Text] [Related]
15. Impact of Plerixafor Use at Different Peripheral Blood CD34
Shah EE; Young RP; Wong SW; Damon LE; Wolf JL; Shah ND; Leavitt AD; Loeffler P; Martin TG
Biol Blood Marrow Transplant; 2020 May; 26(5):876-883. PubMed ID: 31785375
[TBL] [Abstract][Full Text] [Related]
16. Plerixafor-based mobilization in pediatric healthy donors with unfavorable donor/recipient body weight ratio resulted in a better CD34
Zubicaray J; Galvez E; Sebastian E; Molina B; González-Vicent M; Castillo A; Ramírez M; Madero L; Díaz MA; Sevilla J
J Clin Apher; 2021 Feb; 36(1):78-86. PubMed ID: 33079424
[TBL] [Abstract][Full Text] [Related]
17. Collection of blood stem cells from patients with sickle cell anemia.
Richard RE; Siritanaratkul N; Jonlin E; Skarpidi E; Heimfeld S; Blau CA
Blood Cells Mol Dis; 2005; 35(3):384-8. PubMed ID: 16125985
[TBL] [Abstract][Full Text] [Related]
18. The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by "on-demand" addition of plerixafor to granulocyte-colony-stimulating factor.
Girbl T; Lunzer V; Greil R; Namberger K; Hartmann TN
Transfusion; 2014 Sep; 54(9):2325-35. PubMed ID: 24673458
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Hematopoietic Stem Cell Mobilization Rates with Early Plerixafor Administration for Adult Stem Cell Transplantation.
Stover JT; Shaw JR; Kuchibhatla M; Horwitz ME; Engemann AM
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1290-1294. PubMed ID: 28411174
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma.
Cashen A; Lopez S; Gao F; Calandra G; MacFarland R; Badel K; DiPersio J
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1253-61. PubMed ID: 18940680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
